Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Improving survival outcome among elderly lung transplant recipients.

Kambali S, Mantero AMA, Ghodsizad A, Loebe M, Mirsaeidi M.

Eur J Intern Med. 2020 Jan 27. pii: S0953-6205(20)30012-1. doi: 10.1016/j.ejim.2020.01.012. [Epub ahead of print] No abstract available.

PMID:
32001096
2.

Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis.

Nasiri MJ, Ebrahimi G, Arefzadeh S, Zamani S, Nikpor Z, Mirsaeidi M.

Expert Rev Anti Infect Ther. 2020 Jan 27:1-11. doi: 10.1080/14787210.2020.1720650. [Epub ahead of print]

PMID:
31986933
3.

Association of Serum Albumin and Severity of Pulmonary Embolism.

Omar HR, Mirsaeidi M, Rashad R, Hassaballa H, Enten G, Helal E, Mangar D, Camporesi EM.

Medicina (Kaunas). 2020 Jan 9;56(1). pii: E26. doi: 10.3390/medicina56010026.

4.

Mycobacterium abscessus-Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling.

Zhang C, Asif H, Holt GE, Griswold AJ, Campos M, Bejarano P, Fregien NL, Mirsaeidi M.

Front Immunol. 2019 Dec 9;10:2888. doi: 10.3389/fimmu.2019.02888. eCollection 2019.

5.

Effects of 100 % oxygen during exercise in patients with interstitial lung disease.

Cournoyer J, Ramos CF, Sturgill B, Tang F, DeLuca N, Mirsaeidi M, Jackson RM.

Respir Physiol Neurobiol. 2020 Mar;274:103367. doi: 10.1016/j.resp.2019.103367. Epub 2020 Jan 3.

PMID:
31911201
6.

Metabolomic and metallomic profile differences between Veterans and Civilians with Pulmonary Sarcoidosis.

Banoei MM, Iupe I, Bazaz RD, Campos M, Vogel HJ, Winston BW, Mirsaeidi M.

Sci Rep. 2019 Dec 20;9(1):19584. doi: 10.1038/s41598-019-56174-8.

7.

Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance.

Allahyartorkaman M, Mirsaeidi M, Hamzehloo G, Amini S, Zakiloo M, Nasiri MJ.

Sci Rep. 2019 Dec 6;9(1):18515. doi: 10.1038/s41598-019-55112-y.

8.

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management.

Mirsaeidi M, Barletta P, Glassberg MK.

Front Med (Lausanne). 2019 Oct 31;6:248. doi: 10.3389/fmed.2019.00248. eCollection 2019. Review.

9.

Hepatic Sarcoidosis: Natural History and Management Implications.

Sedki M, Fonseca N, Santiago P, Diaz L, Garcia-Buitrago M, Mirsaeidi M, Levy C.

Front Med (Lausanne). 2019 Oct 30;6:232. doi: 10.3389/fmed.2019.00232. eCollection 2019.

10.

Serum Albumin as a Biomarker of Pulmonary Sarcoidosis Chronicity.

Isma SJ, Omar HR, Sweiss N, Mirsaeidi M.

Turk Thorac J. 2019 Aug 19;20(4):236-240. doi: 10.5152/TurkThoracJ.2018.094.

11.

Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10.

Kamran-Sarkandi M, Behrouzi A, Fateh A, Vaziri F, Mirsaeidi M, Siadat SD.

Int J Mol Cell Med. 2018 Fall;7(4):241-250. doi: 10.22088/IJMCM.BUMS.7.4.241. Epub 2019 Apr 7.

12.

Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.

Zhang C, Cai R, Lazerson A, Delcroix G, Wangpaichitr M, Mirsaeidi M, Griswold AJ, Schally AV, Jackson RM.

Lung. 2019 Oct;197(5):541-549. doi: 10.1007/s00408-019-00257-w. Epub 2019 Aug 7.

13.

The Importance of Melanocortin Receptors and Their Agonists in Pulmonary Disease.

Moscowitz AE, Asif H, Lindenmaier LB, Calzadilla A, Zhang C, Mirsaeidi M.

Front Med (Lausanne). 2019 Jun 27;6:145. doi: 10.3389/fmed.2019.00145. eCollection 2019. Review.

14.

An update on IgG4-related lung disease.

Morales AT, Cignarella AG, Jabeen IS, Barkin JS, Mirsaeidi M.

Eur J Intern Med. 2019 Aug;66:18-24. doi: 10.1016/j.ejim.2019.06.010. Epub 2019 Jun 19. Review.

PMID:
31227290
15.

Electronic Cigarettes Enhance Replication of Mycobacterium abscessus in Airway Epithelial Cells.

Korukonda A, Zhang C, Rodriguez L, Guerrero A, Campos M, Holt G, Fregien NL, Conner G, Mirsaeidi M.

Am J Respir Cell Mol Biol. 2019 Jun;60(6):717-719. doi: 10.1165/rcmb.2018-0339LE. No abstract available.

PMID:
31149845
16.

Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease.

Marras TK, Mirsaeidi M, Vinnard C, Chan ED, Eagle G, Zhang R, Wang P, Zhang Q.

J Med Econ. 2019 Nov;22(11):1126-1133. doi: 10.1080/13696998.2019.1620243. Epub 2019 Jun 10.

PMID:
31094592
17.

The unexplained increase of nontuberculous mycobacteriosis.

Rivero-Lezcano OM, González-Cortés C, Mirsaeidi M.

Int J Mycobacteriol. 2019 Jan-Mar;8(1):1-6. doi: 10.4103/ijmy.ijmy_18_19. Review.

18.

Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus.

Khosravi AD, Mirsaeidi M, Farahani A, Tabandeh MR, Mohajeri P, Shoja S, Hoseini Lar KhosroShahi SR.

Infect Drug Resist. 2018 Dec 7;11:2521-2532. doi: 10.2147/IDR.S187554. eCollection 2018.

19.

Impact of seasonal variation in meteorological conditions on dry eye severity.

Dermer H, Galor A, Hackam AS, Mirsaeidi M, Kumar N.

Clin Ophthalmol. 2018 Nov 29;12:2471-2481. doi: 10.2147/OPTH.S181637. eCollection 2018.

20.

Mycobacterium avium complex infection in patients with human immunodeficiency virus: A systematic review and meta-analysis.

Heidary M, Nasiri MJ, Mirsaeidi M, Jazi FM, Khoshnood S, Drancourt M, Darban-Sarokhalil D.

J Cell Physiol. 2019 Jul;234(7):9994-10001. doi: 10.1002/jcp.27859. Epub 2018 Dec 12. Review.

PMID:
30548598

Supplemental Content

Loading ...
Support Center